ESTRO meets Asia 2024 - Abstract Book

S270

Interdisciplinary – SBRT

ESTRO meets Asia 2024

• Kimura T, Fujiwara T, Kameoka T, Adachi Y, Kariya S. The current role of stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC). Cancers. 2022 Sep 8;14(18):4383.

• Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High dose per fraction, hypofractionated treatment effects in the clinic (HyTEC): an overview. International journal of radiation oncology, biology, physics. 2021 May 1;110(1):1-0. • Scorsetti, M., Comito, T., Cozzi, L., Clerici, E., Tozzi, A., Franzese, C., Navarria, P., Fogliata, A., Tomatis, S., D’Agostino, G. and Iftode, C., 2015. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single institutional experience on stereotactic body radiation therapy (SBRT). Journal of cancer research and clinical oncology, 141, pp.1301-1309. • Baumann BC, Wei J, Plastaras JP, Lukens JN, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K. Stereotactic body radiation therapy (SBRT) for hepatocellular Carcinoma. American journal of clinical oncology. 2018 Nov 1;41(11):1118-24.